» Articles » PMID: 14724562

Transmembrane Proteases in Cell Growth and Invasion: New Contributors to Angiogenesis?

Overview
Journal Oncogene
Date 2004 Jan 16
PMID 14724562
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Transmembrane proteases (TPs) are proteins anchored in the plasma membrane with their catalytic site exposed to the external surface of the membrane. TPs are widely expressed, and their dysregulated expression is associated with cancer, infection, inflammation, autoimmune and cardiovascular diseases, all diseases where angiogenesis is part of the pathology. TPs participate in extracellular proteolysis (degradation of extracellular matrix components, regulation of chemokine activity, release of membrane-anchored cytokines, cytokine receptors and adhesion molecules) and influence cell functions (growth, secretion of angiogenic molecules, motility). Recent attention has been focused on the ADAM-17 (a disintegrin and metalloprotease)/TACE/CD156q, the MT1-MMP (membrane-type-1 matrix metallo proteinase)/MMP-14, and the ectopeptidases aminopeptidase N (APN/CD13), dipeptidyl peptidase IV (DPPIV/CD26) and angiotensin-converting enzyme (ACE/CD143), that appear to have a critical role in angiogenesis. This article summarizes current knowledge on these TPs, and reviews recent investigations that document their participation during angiogenic-related events. Through their multiple roles, TPs may thereby provide critical links in angiogenesis.

Citing Articles

Tryptase and tumor angiogenesis.

Ribatti D Front Oncol. 2025; 14:1500482.

PMID: 39749033 PMC: 11693740. DOI: 10.3389/fonc.2024.1500482.


Integrated gene-metabolite association network analysis reveals key metabolic pathways in gastric adenocarcinoma.

Xu B, Shi Y, Yuan C, Wang Z, Chen Q, Wang C Heliyon. 2024; 10(17):e37156.

PMID: 39319160 PMC: 11419903. DOI: 10.1016/j.heliyon.2024.e37156.


Helical ultrastructure of the metalloprotease meprin α in complex with a small molecule inhibitor.

Bayly-Jones C, Lupton C, Fritz C, Venugopal H, Ramsbeck D, Wermann M Nat Commun. 2022; 13(1):6178.

PMID: 36261433 PMC: 9581967. DOI: 10.1038/s41467-022-33893-7.


Validating Cell Surface Proteases as Drug Targets for Cancer Therapy: What Do We Know, and Where Do We Go?.

Verhulst E, Garnier D, De Meester I, Bauvois B Cancers (Basel). 2022; 14(3).

PMID: 35158891 PMC: 8833564. DOI: 10.3390/cancers14030624.


Protease Inhibitors from Plants as Therapeutic Agents- A Review.

Cid-Gallegos M, Corzo-Rios L, Jimenez-Martinez C, Sanchez-Chino X Plant Foods Hum Nutr. 2022; 77(1):20-29.

PMID: 35000105 DOI: 10.1007/s11130-022-00949-4.